Cincinnati, Ohio — SeCQure Surgical, a global provider of devices for open and minimally invasive surgery, has signed a definitive agreement to acquire Atrium Medical Corporation’s hernia mesh line of products. The purchase includes all manufacturing, distribution, and commercial assets, including future products currently in development. Atrium Medical Corporation’s biosurgery business comprises an extensive family of coated and non-coated mesh products, including C-QUR®, PROLOOP® and PROLITE®. These well-established meshes for soft tissue repair cover all types of laparoscopic and open hernia procedures. Joseph Tang, CEO of SeCQure Surgical states, “The acquisition of this well-respected line of implantable materials for soft tissue repair will greatly complement our current offering of surgical staplers and energy devices, and delivers on our commitment to build a world-class surgical portfolio for our customers worldwide.” Under the contract, SeCQure Surgical will start distribution of Atrium’s meshes worldwide on January 1, 2019. Customers will continue to be serviced and orders placed through their current channels. SeCQure Surgical has put together a dedicated team of seasoned professionals to develop and innovate the hernia mesh business and expand its distribution. SeCQure Surgical will work closely with its network of surgeons, clinicians, and healthcare providers to deliver safe and effective solutions for hernia repair surgery.